Antiretrovirals and Risk of COVID-19 Diagnosis and Hospitalization in HIV-Positive Persons
Miguel A. Hernán(Harvard University), Inmaculada Jarrín(Instituto de Salud Carlos III), Asunción Díaz(Instituto de Salud Carlos III), José Ramón Arribas(Hospital Universitario La Paz), Santiago Moreno(Universidad El Bosque), Rosa Polo(Ministry of Health), Estebán Martínez(Instituto de Salud Carlos III)
Cited by 36
Related Papers
Vitamin D intake and incidence of multiple sclerosis
|Neurology|2004|1.1k
Factors Associated With Death in Critically Ill Patients With Coronavirus Disease 2019 in the US
|JAMA Internal Medicine|2020|1k
Tenofovir DF, Emtricitabine, and Efavirenz vs. Zidovudine, Lamivudine, and Efavirenz for HIV
|New England Journal of Medicine|2006|886
Observational Studies Analyzed Like Randomized Experiments
|Epidemiology|2008|814
Activated Injectable Vitamin D and Hemodialysis Survival
|Journal of the American Society of Nephrology|2005|784